Merit Operating Cycle from 2010 to 2026

MMSI Stock  USD 74.85  1.65  2.16%   
Merit Medical's Operating Cycle is increasing with slightly volatile movements from year to year. Operating Cycle is estimated to finish at 222.71 this year. For the period between 2010 and 2026, Merit Medical, Operating Cycle quarterly trend regression had mean deviation of  17.05 and range of 80.0839. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
210.47262017
Current Value
222.71
Quarterly Volatility
21.06370162
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Merit Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Merit Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 141.4 M, Interest Expense of 27.8 M or Total Revenue of 1.6 B, as well as many indicators such as Price To Sales Ratio of 2.74, Dividend Yield of 0.0 or PTB Ratio of 3.62. Merit financial statements analysis is a perfect complement when working with Merit Medical Valuation or Volatility modules.
  
Build AI portfolio with Merit Stock
Check out the analysis of Merit Medical Correlation against competitors.
The Operating Cycle trend for Merit Medical Systems offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Merit Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Merit Medical's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of Merit Medical Systems over the last few years. It is Merit Medical's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Merit Medical's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

Merit Operating Cycle Regression Statistics

Arithmetic Mean194.31
Geometric Mean193.16
Coefficient Of Variation10.84
Mean Deviation17.05
Median198.51
Standard Deviation21.06
Sample Variance443.68
Range80.0839
R-Value0.83
Mean Square Error145.29
R-Squared0.69
Significance0.000034
Slope3.47
Total Sum of Squares7,099

Merit Operating Cycle History

2026 222.71
2025 210.47
2024 212.92
2023 219.62
2022 210.24
2021 196.13
2020 188.26

About Merit Medical Financial Statements

Investors use fundamental indicators, such as Merit Medical's Operating Cycle, to determine how well the company is positioned to perform in the future. Although Merit Medical's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Operating Cycle 210.47  222.71 

Currently Active Assets on Macroaxis

When determining whether Merit Medical Systems offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Merit Medical's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Merit Medical Systems Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Merit Medical Systems Stock:
Check out the analysis of Merit Medical Correlation against competitors.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is there potential for Health Care Equipment & Supplies market expansion? Will Merit introduce new products? Factors like these will boost the valuation of Merit Medical. Expected growth trajectory for Merit significantly influences the price investors are willing to assign. Understanding fair value requires weighing current performance against future potential. All the valuation information about Merit Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.388
Earnings Share
2.13
Revenue Per Share
25.625
Quarterly Revenue Growth
0.109
Return On Assets
0.0475
Investors evaluate Merit Medical Systems using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Merit Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. External factors like market trends, sector rotation, and investor psychology can cause Merit Medical's market price to deviate significantly from intrinsic value.
Understanding that Merit Medical's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Merit Medical represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Merit Medical's market price signifies the transaction level at which participants voluntarily complete trades.